Gadolinium nanoparticles as diagnostic and therapeutic agents: Their delivery systems in magnetic resonance imaging and neutron capture therapy

被引:102
作者
Narmani, Asghar [1 ]
Farhood, Bagher [2 ]
Haghi-Aminjan, Hamed [3 ]
Mortezazadeh, Tohid [4 ]
Aliasgharzadeh, Akbar [2 ]
Mohseni, Mehran [2 ]
Najafi, Masoud [5 ]
Abbasi, Hadis [6 ]
机构
[1] Univ Tehran, Fac New Sci & Technol, Dept Life Sci Engn, Tehran 1439957131, Iran
[2] Kashan Univ Med Sci, Fac Paramed Sci, Dept Med Phys & Radiol, Kashan, Iran
[3] Univ Tehran Med Sci, Dept Pharmacol & Toxicol, Fac Pharm, Tehran, Iran
[4] Univ Tehran Med Sci, Med Phys & Med Engn Dept, Fac Med, Tehran, Iran
[5] Kermanshah Univ Med Sci, Sch Paramed Sci, Radiol & Nucl Med Dept, Kermanshah, Iran
[6] Islamic Azad Univ, North Tehran Branch, Microbiol Dept, Tehran 1667914161, Iran
关键词
Gadolinium; Nanoparticle; MRI; NCT; Delivery systems; MRI CONTRAST AGENTS; TRANSPORT BLOOD SUBSTITUTES; DOPED SILICA NANOPARTICLES; POORLY SOLUBLE DRUGS; IN-VIVO; GD-DTPA; ATHEROSCLEROTIC PLAQUE; OXYGEN-TRANSPORT; UP-CONVERSION; PHYSICOCHEMICAL PROPERTIES;
D O I
10.1016/j.jddst.2018.01.011
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Gadolinium (Gd) chelates have been widely used as contrast agent in magnetic resonance imaging (MRI). In addition to using MRI, they are interesting, as a radiosensitizer, in neutron capture therapy (NCT). However, the poor selective tissue labeling and localization provided by conventional molecular Gd chelates have confined success in both MRI and NCT applications. To encapsulate Gd into nanoparticulate materials can be considered as a method to overcome these limitations. In this regard, developing various carrier systems have increased the sensitivity and improving the targetability of the contrast agents. In this review article, an overview of the delivery systems of Gd nanoparticles in the MRI and NCT would be mentioned.
引用
收藏
页码:457 / 466
页数:10
相关论文
共 127 条
[91]   Nanostructures in biodiagnostics [J].
Rosi, NL ;
Mirkin, CA .
CHEMICAL REVIEWS, 2005, 105 (04) :1547-1562
[92]  
Roux S., 2010, Imaging Med., V2, P211, DOI [10.2217/iim.10.5, DOI 10.2217/IIM.10.5]
[93]   Conjugation of biomolecules with luminophore-doped silica nanoparticles for photostable biomarkers [J].
Santra, S ;
Zhang, P ;
Wang, KM ;
Tapec, R ;
Tan, WH .
ANALYTICAL CHEMISTRY, 2001, 73 (20) :4988-4993
[94]   Development of novel dye-doped silica nanoparticles for biomarker application [J].
Santra, S ;
Wang, KM ;
Tapec, R ;
Tan, WH .
JOURNAL OF BIOMEDICAL OPTICS, 2001, 6 (02) :160-166
[95]   Gd nanoparticulates: from magnetic resonance imaging to neutron capture therapy [J].
Sharma, Parvesh ;
Brown, Scott C. ;
Walter, Glenn ;
Santra, Swadeshmukul ;
Scott, Edward ;
Ichikawa, Hideki ;
Fukumori, Yoshinobu ;
Moudgil, Brij M. .
ADVANCED POWDER TECHNOLOGY, 2007, 18 (06) :663-698
[96]   Luminescent rare earth nanomaterials for bioprobe applications [J].
Shen, Jie ;
Sun, Ling-Dong ;
Yan, Chun-Hua .
DALTON TRANSACTIONS, 2008, (42) :5687-5697
[97]   In vitro cellular accumulation of gadolinium incorporated into chitosan nanoparticles designed for neutron-capture therapy of cancer [J].
Shikata, F ;
Tokumitsu, H ;
Ichikawa, H ;
Fukumori, Y .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2002, 53 (01) :57-63
[98]   Interstitial magnetic resonance lymphography: Comparative animal study of gadofluorine 8 and gadolinium diethylenetriamine-pentaacetic acid [J].
Shimada, M ;
Yoshikawa, K ;
Suganuma, T ;
Kayanuma, H ;
Inoue, Y ;
Ito, K ;
Senoo, A ;
Hayashi, S .
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 2003, 27 (04) :641-646
[99]  
Sirol M, 2004, CIRCULATION, V110, P38
[100]  
Sirol M, 2004, EUR HEART J, V25, P146